Introduction
T emporary dressings are important in the treatment of burn wounds because they help to reduce the risk of infection, prevent and minimize fluid loss, alleviate pain, and promote wound healing. 1, 2 Amniotic membrane (AM) has been used in numerous clinical wound-healing applications and has proven itself to be an efficacious biological dressing in the management of full-and partial-thickness burns, skin graft donor sites, and chronic leg ulcers. 3, 4 The therapeutic effects of AM are attributed to its biocompatibility; specifically, AM stimulates granulation tissue formation, promotes re-epithelialization of the wounded area, reduces scarring, and displays anti-inflammatory and antiimmunogenic properties. 5 These benefits are due largely to the biological composition of AM as it contains several extracellular matrix (ECM) proteins, cytokines, growth factors, and other signaling molecules that are critical to cell infiltration, attachment, and proliferation that greatly impact the overall wound healing process. [6] [7] [8] The preparation, preservation, and storage conditions of AMs are extremely important. Numerous techniques and methodologies have been reported, including treatment with chemical detergents, gamma irradiation, and preservation in glycerol. 9 Cryopreservation of tissue in glycerol is a commonly used technique (e.g., BioTissue, Inc., Miami, FL) because the ECM proteins and growth factors inherent to AM are maintained. However, cryopreservation with glycerol does not generate a sterilized product. 10 Exposure to gamma irradiation is an effective method of sterilization, but results in severe degradation of the collagenous stroma of the AM. 9, 11 Therefore, careful selection of the processing and sterilization procedures for AM is of paramount importance for the preservation of key molecules unique to the tissue matrix.
An alternative to these traditional tissue processing techniques involves the use of supercritical carbon dioxide (SCCO 2 ). The term supercritical fluid denotes a substance that, at temperature and pressure conditions above its critical point, simultaneously exhibits gaseous viscosity and diffusion properties, but liquid densities and dissolution properties. Such characteristics can easily be manipulated with small changes in temperature and pressure, thus making supercritical fluids applicable to many industrial and laboratory processes. [12] [13] [14] Of particular interest is the use of SCCO 2 15 Others have used SCCO 2 to remove cell nuclei from soft tissue as well. In a study of porcine aortas exposed to SCCO 2 , researchers were able to remove the nuclear material with 20 min of exposure. 16 SCCO 2 can also be used to terminally sterilize medical devices, implants, and allograft tissues. After 1 h of exposure to SCCO 2 , spore preparations of Bacillus subtilis and Bacillus stearothermophilus were inactivated and a sterility assurance level (SAL) of 10 -6 (reduction in bacterial spore colonyforming units [CFUs]) was achieved. Scanning electron microscopy (SEM) revealed that the bacteria exposed to SCCO 2 remained intact; however, the lipid bilayer and internal cell structures were indistinguishable. Such results suggest that the mechanism of bacterial inactivation occurs through intracellular acidification due to enhanced mass transfer of CO 2 and disruption of the phospholipid bilayer. 17 The use of SCCO 2 for preparing tissues for transplantation and other clinical applications is only beginning to be realized. SCCO 2 makes an attractive solvent for tissue processing for many reasons. First, SCCO 2 has low-viscosity and highdiffusion coefficients that allow it to penetrate solid microporous matrices, such as tissue ECM. In addition, CO 2 has relatively low critical coordinates (i.e., 93.2-98.7 atm and 35-39°C), making it ideal for delicate biological tissues. The low temperature of the process and the stability of CO 2 allow unwanted compounds, such as blood and lipids, to be extracted without compromising the physiological properties and mechanical integrity of the tissue. 18 Furthermore, SCCO 2 is relatively nontoxic, thus allowing for maintained biocompatibility upon transplantation.
To date, the use of SCCO 2 to prepare and sterilize AM tissue for use in clinical applications has not been investigated, but is an appealing alternative to currently used AM tissue preparation methods. The objective of this study was to produce a sterile, biocompatible tissue allograft made of human AM that can be used in tissue engineering and regenerative medicine applications utilizing SCCO 2 technology.
Materials and Methods

Preparation of AM
Placentas from consenting mothers undergoing elective caesarean sections were acquired from the University Hospital (San Antonio, TX). The AM was isolated from the placenta using blunt dissection under sterile conditions. Once removed, the AM was thoroughly rinsed in saline to remove any remaining chorion, blood clots, and general debris. AM was placed epithelial side up on nitrocellulose paper (0.45 mm; Whatman), which were then sealed in DuPontÔ Tyvek Ò packaging and kept frozen at -80°C before being exposed to SCCO 2 .
Validation of tissue sterility
Tissue sterility experiments were carried out in accordance with industrial sterilization validation guidelines. 19, 20 Bacterial strains used included a clinical isolate of Staphylococcus epidermidis (obtained from San Antonio Military Medical Center, Fort Sam Houston, TX) and a spore suspension of Clostridium sporogenes (SGM Biotech/Mesa Labs, Bozeman, MT).
Each AM tissue piece, measuring 2.54 cm 2 , was inoculated with 10 6 CFU of either the S. epidermidis or C. sporogenes. Inoculated tissues were double packaged in Tyvek pouches and heat-sealed before exposure to the sterilization treatment. Sterilization consisted of exposing the tissue to SCCO 2 for 10-30 min with the addition of 0-2 mL of peracetic acid (PAA). Untreated AM tissue inoculated with bacteria/spores and the broth solutions alone served as controls. AM tissue was exposed to SCCO 2 using a Nova 2200 SCCO 2 sterilizer (NovaSterilis, Lansing, NY). The pressure and temperature of the SCCO 2 were held constant at 9900 kPa and 35°C, respectively (Fig. 1) .
After sterilization, the AM tissues inoculated with S. epidermidis were placed in tubes containing nutrient broth and incubated at 37°C for 14 days. Similarly, tissue samples inoculated with C. sporogenes were placed in reinforced clostridium broth following sterilization and cultured under anaerobic conditions; that is, in an anaerobic chamber 
Histology
Native and SCCO 2 -treated AM were fixed in 10% neutral buffered formalin overnight. The AM pieces were then embedded in paraffin by standard techniques and sectioned with a microtome. Cut sections were stained with picrosirius red (PSR; Polysciences, Inc., Warrington, PA). PSR stain in conjunction with polarized light microscopy was used to enhance the inherent birefringence of collagen molecules, thus allowing for the evaluation of collagen fiber organization of SCCO 2 -treated AM as compared with native tissue. Briefly, sections were deparaffinized and hydrated with distilled water and stained with Hematoxylin. Sections were then incubated in sirius red F3B solution for 1 h, washed in 0.01 N hydrochloric acid (HCl), and then dehydrated, cleared, and mounted. Images of the stained tissue sections were acquired with an Olympus BX60 microscope (Center Valley, PA) equipped with the appropriate filters for polarized light.
Scanning electron microscopy
Native and SCCO 2 -treated AM tissues were prepared for SEM following standard procedures. 21 Briefly, tissues were fixed in 2.5% phosphate buffered glutaraldehyde at 4°C for 1 h, dehydrated in a series of graded alcohols (50%, 70%, 80%, 90%, 95%, and 100%) and dried using hexamethyldisilazane (Electron Microscopy Sciences, Hatfield, PA). The samples were then sputter coated with a thin layer (10 nm) of gold and palladium (Anatech, Union City, CA), and examined on a Zeiss Sigma VP 40 (Zeiss-Leica, Thornwood, NY) scanning electron microscope.
Immunohistochemical staining
The ECM of SCCO 2 -treated AM tissue was also evaluated immunohistochemically. Briefly, cleared and dehydrated AM tissue sections were rinsed in a solution of Tris buffered saline (TBS; Fisher, Fair Lawn, NJ) with 0.025% Triton X-100 (Sigma Aldrich, St. Louis, MO) and then blocked for 2 h at room temperature using a solution of 10% horse serum (Gibco, Grand Island, NY) and 1% bovine serum albumin (BSA; Sigma Aldrich) in TBS. Following blocking, tissue sections were incubated with the primary antibody, a mouse monoclonal antibody specific to type I collagen (Abcam, Cambridge, MA), diluted 1:400 in TBS with 1% BSA at 4°C overnight. Next, sections were rinsed in TBS/0.025% Triton X-100 and then incubated in 0.3% hydrogen peroxide (Henry Schein, Melville, NY) at room temperature for 15 min to block endogenous peroxidase activity. Sections were washed in TBS and incubated with a biotinylated horse anti-mouse IgG secondary antibody (1:250 dilution; Vector, Burlingame, CA) at room temperature for 1 h, rinsed in TBS again, then incubated in Vecstatin ABC reagent (Vector) at 37°C for 30 min before development with diaminobenzidine (Vector).
The sections were finally rinsed in running tap water and counterstained with methyl green (Vector). Stained sections were then dehydrated, cleared, and mounted. Images of the stained tissue sections were acquired with an Olympus BX60 microscope.
The plasma membranes of the epithelium of native and SCCO 2 -treated AMs were fluorescently labeled. Briefly, whole pieces of AM tissue were fixed in acetone at -20°C for 3 min, rinsed in Hank's balance salt solution (HBSS; Life Technologies, Eugene, OR) and then incubated at 37°C in 10 mg/mL of CellMaskÔ Deep Red Plasma membrane stain (Molecular Probes) solution for 5 min. The labeled AM tissues were again rinsed in HBSS before being mounted in ProLong Gold Antifade reagent (Molecular Probes) and imaged. Fluorescent images of the cell membranes were obtained using the appropriate filters (649/ 666 nm excitation/emission).
Differential scanning calorimetry
The thermal transitions of the SCCO 2 -treated AMs were analyzed by differential scanning calorimetry (DSC) using a Perkin Elmer DSC7 (Waltham, MA). Native and SCCO 2 -treated AM tissues were lyophilized overnight, weighed (5 mg dry weight per sample), then sealed in aluminum pans before being heated at a rate of 30°C/min over a temperature range of 25-300°C. An empty aluminum pan served as the reference for all samples tested. DSC thermograms were collected using the accompanying Pyris software, and the temperatures at which the thermal transition peaks occurred were identified. The transition temperatures, an indicator of the resistance of a material to heat denaturation, were defined as the peak maximum of the resultant endothermic peaks. Results from three separate trials were averaged. A second thermal run on the native tissue was performed to compare the transitions of a denatured tissue sample.
Fourier Transform Infrared spectroscopy
Changes in the chemical structures of AM after treatment with SCCO 2 were evaluated using the Fourier Transform Infrared (FTIR) spectroscopy. Spectra for native and SCCO 2 -treated AM were acquired using a Tensor 27 spectrometer (Bruker, Billerica, MA). Spectral scanning in the range of 4500-400 cm -1 with a resolution of 4 cm -1 was performed and the absorbance at each wavelength recorded for all samples using the OPUS software.
Biochemical characterization
The amounts of hydroxyproline, type IV collagen, elastin, and glycosaminoglycans (GAGs) present in native (n = 6) and SCCO 2 -treated tissues (n = 6) were quantified with commercially available assays: hydroxyproline (BioVision, Mountain View, CA); type IV collagen enzyme-linked immunosorbent assay (ELISA) (Exocell, Philadelphia, PA); FastinÔ Elastin Assay (Biocolor, Northern Ireland, United Kingdom); and Blyscan sulfated GAG assay (Biocolor), respectively. All assays were conducted following the manufacturer's recommended procedures. Briefly, tissue samples were lyophilized overnight, and the dry weight measured. For the hydroxyproline assay, the AM tissue was completely solubilized in 12 N HCl at 100°C for 3 h. For the extraction of type IV collagen and the GAGs, the tissue was digested in a papain extraction reagent consisting of 0.2 M sodium phosphate buffer, sodium acetate, ethylenediaminetetraacetic acid (EDTA), cysteine HCl, and papain at 65°C overnight. Elastin was extracted by incubating tissue samples in 0.25 M oxalic acid at 60°C for 1 h. The elastin extraction process was repeated with fresh oxalic acid, and the two extractions were pooled for analysis. The concentrations of hydroxyproline, type IV collagen, elastin, and GAGs contained in each sample tested were determined using a standard curve of light absorbance (560, 450, 513, and 656 nm for hydroxyproline, type IV collagen, elastin, and GAGs, respectively) versus known concentrations of each protein run in parallel with the experimental samples.
The degree of collagen denaturation after SCCO 2 treatment was also assessed using an a-chymotrypsin assay following previously published procedures. 22 Briefly, lyophilized AM was incubated in 0.1 M tris HCl containing 1 mg/mL a-chymotrypsin (Sigma Aldrich), 1 mM iodoacetamide, and 1 mM ethylenediaminetetraacetic acid (Sigma Aldrich) overnight at 37°C to digest denatured collagen within the matrix. The supernatant, containing the degraded collagen, was solubilized and the amount of hydroxyproline determined. The amount of hydroxyproline obtained from denatured collagen was expressed as a percentage of the total hydroxyproline content.
Adipose-derived stem cell culture
The biocompatibility of AM tissue exposed to SCCO 2 was evaluated in vitro using human adipose-derived stem cells (hASCs) previously isolated in our laboratory. 23 The hASCs were maintained in MesenPRO RSÔ basal medium supplemented with MesenPRO RS growth supplement, an antibiotic-antimycotic solution (100 U/mL penicillin G, 100 mg/mL streptomycin sulfate, and 0.25 mg/mL amphotericin B), and 2-mM L-glutamine (Gibco, Invitrogen, Carlsbad, CA) under standard cell culture conditions (i.e., a sterile, 37°C, humidified, 5% CO 2 /95% air environment). Cells at passage 2-4 were used in experiments.
ASC attachment and proliferation SCCO 2 -treated AMs were placed inside 12-well cell culture inserts (BD Biosciences, Franklin Lakes, NJ) with the epithelial side facing upward. The hASCs fluorescently labeled with carboxyfluorescein diacetate, succinimidyl ester (Life Technologies) were seeded (50,000 cells per insert) on top of the AMs and maintained, submerged in culture medium, over a period of 4 days. Cell attachment was assessed 24 h postseeding, and fluorescent images were taken with an Olympus IX71 inverted microscope (Olympus America, Inc., Center Valley, PA).
Proliferation was monitored over the 4-day period using the colorimetric MTT [3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] metabolic activity assay (Life Technologies). Briefly, on days 1, 2, 3, and 4, MTT (5 mg/ mL) was added to the inserts. The hASCs were allowed to reduce the tetrazolium salt to formazan over a period of 4 h. At that time, the purple formazan was extracted from the cells and solubilized using dimethyl sulfide (Sigma, St. Louis, MO). The optical density of the resulting solution was determined by measuring the absorbance at 570 nm (630 nm reference) using a microplate reader (Synergy MX; BioTek, Winooski, VT).
Statistical analyses
Statistical analyses of numerical results were performed using the GraphPad Prism (GraphPad Software, Inc., San Diego, CA) statistical software package. Numerical data are expressed as mean -standard error of the mean. Comparisons between groups were made using a one-way analysis of variance (ANOVA) with values of p £ 0.05 considered statistically significant. Post hoc analyses were performed using the Tukey's multiple comparison test.
Results
Tissue sterility
Sterilization of AM inoculated with S. epidermidis and C. sporogenes was achieved with minimal processing time and minimal amounts of PAA sterilizing agent (Table 1) . SCCO 2 alone without the addition of the sterilizing agent PAA was not sufficient to inactivate the S. epidermidis and C. sporogenes bacteria as evidenced by bacterial growth detected 3 days poststerilization treatment. A volume of 0.5 mL of PAA with 10 min of exposure to SCCO 2 was sufficient to inactivate S. epidermidis and inhibit contamination over the 2-week culture period; however, an increase in the duration of SCCO 2 treatment and volume of PAA additive was needed to inactivate C. sporogenes. The amount of PAA needed to inactivate both S. epidermidis and C. sporogenes in the shortest time possible (10 min of SCCO 2 exposure) required using 2 mL of PAA. These treatment parameters were deemed optimal for the production of sterile AM tissue. AMs exposed to this sterilization treatment were further characterized. Two processing parameters, peracetic acid (PAA) and duration of exposure to supercritical carbon dioxide (SCCO 2 ), were evaluated to determine their effectiveness of eliminating bacterial survivors from inoculated AM tissue. ''Pass'' denotes the absence of bacterial growth on the agar plates after the prescribed culture time, whereas ''Fail'' represents observed bacterial growth on the agar culture plates indicating one or more bacterial survivors.
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Histological evaluation of the ECM of SCCO 2 -treated AM
Histological comparisons between native and SCCO 2 -treated AM tissue samples were performed to determine the effects of SCCO 2 treatment on the gross appearance and general structural properties of the tissue ECM (Fig. 2) . Sterilization did not affect the tissue structure and collagen organization ( Fig. 2A, D) . PSR staining of SCCO 2 -treated tissue under polarized light revealed dispersed birefringence with green, yellow, and orange/red coloring present throughout most of the tissue regions (Fig. 2B, E) . The color and intensity of the birefringence were similar to that of native AM. Immunohistochemical observation of SCCO 2 -treated AM showed positive staining for the major ECM protein collagen I throughout the entire cross section of tissue, similar to that of native AM (Fig. 2E, F) .
Assessment of the SCCO 2 -treated amniotic epithelium
The structure and ultrastructure of the AM epithelium were evaluated pre-and poststerilization treatment with SEM and fluorescent microscopy. The epithelium after SCCO 2 treatment appeared flattened with less distinguishable cellular boundaries as compared with native epithelium (Fig. 3A, B) . Further examination of the plasma membrane revealed the SCCO 2 -treated group had no positive staining for membrane lipids (Fig. 3C, D) .
DSC and FTIR spectroscopy analyses of native and SCCO 2 -treated AM
DSC was used to analyze the thermal transitions of native and SCCO 2 -treated AM tissues. As the AM tissue was subjected to a constant heating rate (30°C/min), the collagen molecules present in the tissue underwent thermal dehydration and structural changes as evidenced by the endothermic peaks that appeared on the DSC curves (Fig. 4A) . The first thermal transition occurred at 114.4°C -0.68°C and 113.4°C -0.88°C for native and SCCO 2 -treated membranes, respectively. The second thermal transition occurred at 218.4°C -0.92°C and 220.7°C -1.783°C for native and SCCO 2 -treated membranes, respectively. DSC of denatured native AM did not show characteristic transition peaks. SCCO 2 -treated membranes exhibited amide absorption bands at 1654 cm -1 (amide I), 1552 cm -1 (amide II), and 1238 cm -1 (amide III) similar to those observed in the native membrane (Fig. 5) . Other peaks present in the spectra of both native and SCCO 2 -treated AMs include 3315 and 2925 cm To verify the findings of DSC and FTIR and ensure that the denaturation of collagen proteins was not occurring as a result of the SCCO 2 treatment, the amount of denatured collagen was estimated using an a-chymotrypsin/hydroxyproline assay. The amounts of hydroxyproline from denatured collagen in native AM tissue and from AM tissue that underwent SCCO 2 sterilization were not significantly different. Native AM consisted of 4% hydroxyproline from denatured collagen while SCCO 2 -treated AM contained 5.1% hydroxyproline from denatured collagen (Fig. 4B ).
Biochemical analyses of SCCO 2 -treated AM
Multiple measures of ECM components (hydroxyproline, type IV collagen, elastin, and GAGs) did not significantly differ (n = 6; p > 0.05) between native and SCCO 2 -treated AM (Fig. 6 ). Hydroxyproline present in native and SCCO 2 In vitro biocompatibility of SCCO 2 -treated AM After 24 h of culture hASCs attached to SCCO 2 -treated AM (Fig. 7A) , and continued to proliferate over the next few days (Fig. 7B) as determined by MTT. By day 4, the hASCs had more than doubled in population. An a-chymotrypsin/hydroxyproline assay was used to estimate the amount of denatured collagen in SCCO 2 -treated AM tissue (B). Numerical data are expressed as mean -standard error of the mean of six different samples. Comparisons between groups were made using a t-test with values of p £ 0.05 considered statistically significant.
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Discussion
The detrimental effects that occur as a result of sterilization treatment have the potential to alter or impair the desired function of AM tissue postimplantation. In an attempt to overcome these limitations, we utilized SCCO 2 for the sterilization of AM and then evaluated the effects of SCCO 2 treatment on the physical, chemical, and biological properties of the tissue. The results of this study demonstrate SCCO 2 , when used with PAA, is an effective sterilization method that meets industrial sterility standards (i.e., SAL of 10 -6 ). Furthermore, this method of sterilization is not damaging to the structural and biological properties of the tissue, thus making SCCO 2 -treated AM appealing for clinical applications.
AM tissues have found utility as tissue engineering substrates for regenerative purposes because of their unique ECM compositions. 24, 25 As such, the methodologies used for the preparation, preservation, and storage of AM are extremely important. Cryopreservation in glycerol is the most widely used method of AM tissue graft preservation, introduced by Tseng and colleagues in 1995. 26 Since then, numerous studies have shown that cryopreserved AM is similar to native AM with regard to its structural architecture and biological composition. 7, 9, 27, 28 In addition, cryopreserved AM has demonstrated clinical success when used therapeutically for corneal epithelial defects, cutaneous partial thickness burns, and conjunctival surface reconstruction. [29] [30] [31] However, there exists a fine balance between maintaining the biological and structural integrity of the tissue matrix and meeting the regulatory requirements for sterility imposed upon by the FDA and the American Association of Tissue Banks for the prevention of disease transmission. Although cryopreservation of AM in glycerol is advantageous from a tissue/material perspective, this method, does not ensure complete tissue sterility. 11, 32, 33 Unlike metals and plastics, the sterilization of soft, biological tissues have many challenges. First, the biomechanical and biological properties of the tissue can be adversely affected. For example, gamma irradiation and steam and heat sterilization of soft tissues, and in particular AM, cause significant structural damage through irreversible degradation of ECM proteins. 9, 34 Furthermore, traditional sterilization methods do not penetrate the tissue adequately enough to kill bioburden residing deep within the tissue matrix. Tissue complexity pertinent to intricate ECM architectures along with the presence of an array of organic biomolecules and cells, aids in protecting the bioburden thus making sterilization more difficult. 35 For these reasons, there exists a need for more advanced sterilization technologies that can be used in conjunction with human tissue grafts, more specifically, delicate human AM tissue. Our results showed that sterilization of AM with SCCO 2 overcomes the limitations associated with other sterilization methods specifically in that the SCCO 2 process maintained the structural integrity of the tissue matrix and preserved key ECM proteins while simultaneously inactivating the bioburden. Like other processes currently used in the healthcare industry for the sterilization of tissues and medical devices, SCCO 2 sterilization must be validated in accordance with industrial sterilization standards. 19, 20 Specifically, a SAL of 10 -6 (defined as the probability of a contaminant existing after sterilization treatment to be one in a million after a 10 6 log reduction in bacterial load) 17 must be achieved in order for a claim of sterility to be made. In addition, the bacterial species used in such sterilization validations must be a species that exhibits extreme resistance to inactivation. Spore-forming bacteria are commonly used for this purpose because of their resistance to traditional sterilization processes. 36, 37 In the current study, we used SCCO 2 with minimal amounts of PAA to achieve a SAL 10 -6 against both S. epidermidis (a prevalent bacterial species found on AM) and C. sporogenes (spore-forming bacteria resistant to antimicrobial/sterilization treatments) to meet industrial sterilization requirements. Although four times as much PAA was required for inactivation of C. sporogenes, the amount of PAA used in this study is still significantly less than the amounts typically reported (0.1%) when PAA alone is used for sterilization. 24 Furthermore, combining PAA with SCCO 2 resulted in a relatively short exposure time of the tissue to PAA. By comparison, using PAA alone for the sterilization of tissues, such as skin grafts or urinary bladder matrix, requires anywhere from 3 to 5 h of processing for sterilization to be achieved. 9, 24, 38, 39 To ensure that the sterilization treatment did not result in AM degradation or loss of ECM proteins, we performed microscopic, spectroscopic, thermodynamic, and biochemical analyses on native and SCCO 2 -treated AMs. IR spectroscopy is a useful tool for obtaining molecular-level information pertinent to functional groups, chemical bonds, and molecular confirmations of proteins present in normal, physiological, and pathological tissues. 40, 41 Both FTIR and DSC analyses were carried out to show that SCCO 2 treatment imposes minimal to no changes in molecular organization of ECM protein present in AM. Specifically, FTIR was used as an analytical measure to confirm the presence of collagen, the predominant ECM protein of AM, through signature peaks that are unique to the protein. FTIR spectra of AM tissue treated with SCCO 2 and PAA did not show any considerable differences in the absorption frequencies and peak intensities in comparison to native tissues. Moreover, FTIR analysis did not show any major change in the spectral frequencies corresponding to amide absorption peaks typical to AM and other collagenous tissues. 42 Complementing the FTIR findings, observations of the DSC thermograms confirmed that SCCO 2 treatment does not affect essential ECM elements present within AM. These findings were further validated through DSC analyses and quantified using a collagen degradation assay. Thermal denaturation involves the breaking of intramolecular bonds of the collagen molecules present in the AM tissue, reducing the organized triple helices to a random, amorphous coil form. Any degradation to the collagen molecule brought about as a result of processing techniques would result in a decrease in the thermal transition temperatures of the AMs; however, because no significant changes were observed in the DSC curves between the native and the SCCO 2 -treated AM tissues, we can conclude that the sterilization treatment is not adversely affecting the hydrothermal stability of the AM tissue.
Native amnion consists primarily of type I and III collagens with smaller amounts of collagen types IV-VII. In addition, AM contains significant amounts of the proteoglycans   FIG. 7 . Representative fluorescent micrograph of human adipose-derived stem cells (hASCs) seeded on SCCO 2 -treated AM tissue over a period of 4 days of culture (A). The cells were labeled with carboxyfluorescein succinimidyl ester before seeding and were seeded at a density of 50,000 cells per sample. The hASCs proliferation was monitored with the MTT assay (B). Uptake of the dye increased over a period of 4 days, thus indicating increased cell proliferation. Each bar represents the mean -standard error of the mean of three observations. Color images available online at www .liebertpub.com/tec decorin, biglycan, and hyaluronic acid, as well as GAGs and elastin molecules. [43] [44] [45] Collectively, these biomolecules not only provide tensile strength and impart elasticity to the AM, but facilitate cell function as well. 6, 46 Higa et al. showed greater lymphocyte adhesion to areas of AM ECM containing high levels of the GAG hyaluronic acid, suggesting the entrapment of inflammatory cells to the AM stroma may have a role in suppressing inflammation and fibrosis. 47 While the exact mechanisms are not clearly understood, it is suggested that the presence of antiangiogenic proteins and various growth factors in AM contribute to the beneficial therapeutic effects observed when AM is used clinically in cutaneous wound healing and ocular applications. 7, 8, 28 Although further biochemical testing should to be performed to confirm select growth factors and cytokines are present in SCCO 2 -treated AM, our current findings suggest the SCCO 2 sterilization methodology is compatible with the delicate AM tissue with regard to preserving key biochemical components of the matrix.
Since SCCO 2 sterilization treatment did not cause major structural and biological degradation, the treated membranes were well suited to promote desirable cell interactions. We showed that SCCO 2 -treated AM acts as a bioactive substrate for stem cell attachment and proliferation, making the tissue appealing for wound healing and regenerative medicine applications. It is well known that the degree of cellular attachment, migration, and proliferation on a biological scaffold is mediated by the scaffold's ECM milieu, and in addition, the conditions used to process AM significantly affect cell function in vitro. A recent report showed that limbal epithelial stem cells cultured on glycerol-preserved membrane tissues were less confluent, exhibited lower cell density, and expressed less of their characteristic stem cell markers than cells cultured on AM cryopreserved in buffer alone. 32 In the present study, we showed that hASCs readily attached to the sterilized AM after 24 h, exhibited typical fibroblast-like morphology, and continued to proliferate over time. This shows the potential of AM to act not only as a bioactive cover, but also as a delivery vehicle by which the patient's own cells can be transplanted to the injured area. The SCCO 2 -treated AM is a biomaterial well suited to form the basis of a skin equivalent and may act as a viable substrate for the treatment of a variety of conditions, including burns, ulcers, and for normal physiological wound healing.
Conclusions
The use of SCCO 2 and PAA presents a novel single-step technique to process AM tissue for potential clinical application. SCCO 2 treatment allows for AM to be processed such that the tissue graft is not only sterile, but also has the physical and biochemical properties that are most similar to that of native tissue. Furthermore, SCCO 2 acts as an excellent scaffold for stem cell attachment and proliferation, which potentially could be used as a tissue-engineered substitute for use in wound healing and regenerative medicine applications.
